C World Wide Group Holding A Heron Therapeutics, Inc. Transaction History

C World Wide Group Holding A

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 05, 2021	BUY	$14.61 - $22.14 $4.38 Million - $6.64 Million	300,000 Added 33.26%	1,202,069 $25.4 Million
Q3 2020 Nov 02, 2020	BUY	$13.67 - $17.77 $2.73 Million - $3.55 Million	200,000 Added 28.49%	902,069 $13.4 Million
Q2 2019 Aug 02, 2019	BUY	$16.93 - $26.22 $7.62 Million - $11.8 Million	450,000 Added 178.52%	702,069 $13.1 Million
Q1 2019 May 03, 2019	BUY	$23.15 - $28.34 $2.79 Million - $3.41 Million	120,471 Added 91.54%	252,069 $6.16 Million
Q4 2018 Feb 12, 2019	SELL	$22.03 - $32.01 $1.03 Million - $1.49 Million	-46,685 Reduced 26.19%	131,598 $3.41 Million
Q3 2018 Nov 05, 2018	SELL	$30.0 - $40.85 $981,870 - $1.34 Million	-32,729 Reduced 15.51%	178,283 $5.64 Million
Q2 2018 Aug 03, 2018	BUY	$26.4 - $42.0 $2.56 Million - $4.07 Million	97,002 Added 85.08%	211,012 $8.2 Million
Q1 2018 May 03, 2018	SELL	$18.43 - $28.8 $324,183 - $506,592	-17,590 Reduced 13.37%	114,010 $3.15 Million
Q4 2017 Feb 07, 2018	BUY	$14.8 - $18.85 $467,680 - $595,660	31,600 Added 31.6%	131,600 $2.38 Million
Q3 2017 Nov 06, 2017	BUY	$14.65 - $16.85 $1.47 Million - $1.69 Million	100,000	100,000 $1.62 Million

175

121M

80.4K

94.9K

Ticker HRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,774,000
Market Cap $201M
Description
Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...

Get notified when there are updates to the investment portfolio of C World Wide Group Holding A, based on Form 13F filings with the SEC.

Stay updated on C World Wide Group Holding A with notifications on news.